NCT07277478

Brief Summary

This randomized, single-blind controlled trial examined the effects of auricular acupressure on postpartum women who underwent episiotomy. A total of 86 participants were allocated to either an intervention group, which received routine care plus transparent auricular patches containing magnetic beads applied to selected acupoints, or a control group, which received identical patches without magnetic beads. The patches were applied for 48 hours after delivery. Perineal pain and its impact on daily activities were assessed at 2, 12, 24, and 48 hours postpartum, while satisfaction with perineal pain care was measured at 48 hours. Using independent t-tests, chi-square tests, and generalized estimating equations, the study evaluated whether auricular acupressure reduced perineal wound pain, lessened pain-related interference with daily activities, and improved satisfaction with perineal pain management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 7, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 30, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
Last Updated

December 11, 2025

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

November 30, 2025

Last Update Submit

November 30, 2025

Conditions

Keywords

episiotomyauricular acupressurepainimpact on daily lifesatisfaction with pain management

Outcome Measures

Primary Outcomes (1)

  • perineal pain

    Structured questionnaires were used to assess perineal pain and its impact on daily activities at 2, 12, 24, and 48 hours postpartum.

    At 2, 12, 24, and 48 hours postpartum

Secondary Outcomes (2)

  • impact on daily life

    At 2, 12, 24, and 48 hours postpartum

  • satisfaction with pain management

    At 48 hours postpartum

Study Arms (2)

auricular patch containing magnetic beads

EXPERIMENTAL

After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4).

Device: auricular patch

auricular patch without magnetic beads

PLACEBO COMPARATOR

After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4).

Device: auricular patch

Interventions

After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4)

auricular patch containing magnetic beadsauricular patch without magnetic beads

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with singleton pregnancies who delivered vaginally.
  • Women who underwent episiotomy.
  • Gestational age between 37 and 42 weeks.
  • Willing to participate in the study and provide signed informed consent.
  • Age 18 years or older.

You may not qualify if:

  • Women with skin lesions or allergies at the auricular acupressure site.
  • Women with gynecological disorders, such as uterine fibroids, adenomyosis, or endometriosis.
  • Women or newborns with severe postpartum complications, such as postpartum hemorrhage, infection, perineal hematoma, major neonatal diseases, or admission to the neonatal intensive care unit.
  • Women with psychiatric disorders, such as anxiety or depression.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hsiao Ai Wen

Taipei, Sanchong, 241, Taiwan

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • AI WEN HSIAO

    National Taipei University of Nursing and Health Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
This study design was a randomized controlled single-blind trial.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: participants were postpartum women who had undergone episiotomy and were randomly assigned to the intervention or control group using an Excel-generated random allocation table. A total of 90 patients were enrolled, with 4 excluded, resulting in 43 participants in each group. Demographic data were collected before the intervention. After placental delivery, the intervention group received routine care plus a transparent patented auricular patch containing magnetic beads, while the control group received a transparent patented auricular patch without magnetic beads. The selected acupoints included internal genitalia (TF2), external genitalia (HX4), Shenmen (TF4), sympathetic (AH6a), and subcortex (AT4).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

November 30, 2025

First Posted

December 11, 2025

Study Start

December 7, 2024

Primary Completion

April 10, 2025

Study Completion

September 12, 2025

Last Updated

December 11, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations